Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease.

Bliss SJ, O'Brien KL, Janoff EN, Cotton MF, Musoke P, Coovadia H, Levine OS.

Lancet Infect Dis. 2008 Jan;8(1):67-80. Epub 2007 Oct 31. Review.

PMID:
17974480
2.

The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children.

Thanee C, Pancharoen C, Likitnukul S, Luangwedchakarn V, Umrod P, Phasomsap C, Apornpong T, Chuanchareon T, Butterworth O, Puthanakit T.

Vaccine. 2011 Aug 11;29(35):5886-91. doi: 10.1016/j.vaccine.2011.06.072. Epub 2011 Jul 3. Erratum in: Vaccine. 2011 Oct 26;29(46):8470.

PMID:
21729732
3.

Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals.

Nunes MC, Madhi SA.

Hum Vaccin Immunother. 2012 Feb;8(2):161-73. doi: 10.4161/hv.18432. Epub 2012 Feb 1. Review.

4.

The future of pneumococcal disease prevention.

Rodgers GL, Klugman KP.

Vaccine. 2011 Sep 14;29 Suppl 3:C43-8. doi: 10.1016/j.vaccine.2011.07.047.

PMID:
21896352
5.

HIV Infection and the Epidemiology of Invasive Pneumococcal Disease (IPD) in South African Adults and Older Children Prior to the Introduction of a Pneumococcal Conjugate Vaccine (PCV).

Meiring S, Cohen C, Quan V, de Gouveia L, Feldman C, Karstaedt A, Klugman KP, Madhi SA, Rabie H, Sriruttan C, von Gottberg A; GERMS-SA.

PLoS One. 2016 Feb 10;11(2):e0149104. doi: 10.1371/journal.pone.0149104. eCollection 2016.

6.

Pneumococcal conjugate vaccine--a health priority.

Zar HJ, Madhi SA.

S Afr Med J. 2008 Jun;98(6):463-7.

PMID:
18683380
7.

Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine.

Madhi SA, Adrian P, Kuwanda L, Jassat W, Jones S, Little T, Soininen A, Cutland C, Klugman KP.

Vaccine. 2007 Mar 22;25(13):2451-7. Epub 2006 Sep 20.

PMID:
17023095
8.

Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age.

Lucero MG, Dulalia VE, Nillos LT, Williams G, ParreƱo RA, Nohynek H, Riley ID, Makela H.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD004977. doi: 10.1002/14651858.CD004977.pub2. Review.

PMID:
19821336
9.

Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: South Africa, 2003-2008.

von Gottberg A, Cohen C, de Gouveia L, Meiring S, Quan V, Whitelaw A, Crowther-Gibson P, Madhi SA, Whitney CG, Klugman KP.

Vaccine. 2013 Aug 28;31(38):4200-8. doi: 10.1016/j.vaccine.2013.04.077. Epub 2013 May 16.

PMID:
23684826
10.

Evaluation of humoral response to heptavalent pneumococcal conjugate vaccine in HIV-infected children.

Costa Ide C, Guilardi F, Kmiliauskis MA, Arslanian C, Baldacci ER.

Rev Saude Publica. 2008 Oct;42(5):844-50. Epub 2008 Aug 28. English, Portuguese.

11.

Review on the immunogenicity and safety of PCV-13 in infants and toddlers.

Nunes MC, Madhi SA.

Expert Rev Vaccines. 2011 Jul;10(7):951-80. doi: 10.1586/erv.11.76. Review.

PMID:
21806394
12.

Introduction of pneumococcal conjugate vaccine into the public immunization program in South Africa: translating research into policy.

Madhi SA, Cohen C, von Gottberg A.

Vaccine. 2012 Sep 7;30 Suppl 3:C21-7. doi: 10.1016/j.vaccine.2012.05.055. Review.

PMID:
22939016
13.

Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects.

Davis SM, Deloria-Knoll M, Kassa HT, O'Brien KL.

Vaccine. 2013 Dec 17;32(1):133-45. doi: 10.1016/j.vaccine.2013.05.005. Epub 2013 May 16. Review.

PMID:
23684824
15.

Association of Streptococcus pneumoniae common protein antigen (CPA) antibodies and pneumococcal nasopharyngeal colonization in HIV-infected and HIV-uninfected African children.

Ditse Z, Adrian PV, Kuwanda L, Madhi SA.

Vaccine. 2013 Sep 13;31(40):4421-7. doi: 10.1016/j.vaccine.2013.06.097. Epub 2013 Jul 8.

PMID:
23845819
16.

Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.

Zangeneh TT, Baracco G, Al-Tawfiq JA.

Expert Rev Vaccines. 2011 Mar;10(3):345-53. doi: 10.1586/erv.11.1. Review.

PMID:
21434802
17.

Pneumococcal conjugated vaccine: PHiD-CV.

Dinleyici EC, Yargic ZA.

Expert Rev Anti Infect Ther. 2009 Nov;7(9):1063-74. doi: 10.1586/eri.09.84.

PMID:
19883326
18.

The pharmacoeconomics of pneumococcal conjugate vaccines in Latin America.

Giglio N, Micone P, Gentile A.

Vaccine. 2011 Sep 14;29 Suppl 3:C35-42. doi: 10.1016/j.vaccine.2011.06.095. Review.

PMID:
21896351
19.

Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000-2005.

Harboe ZB, Valentiner-Branth P, Benfield TL, Christensen JJ, Hjuler T, Kaltoft M, Krogfelt KA, Lambertsen L, Konradsen HB.

Vaccine. 2008 Jul 4;26(29-30):3765-71. doi: 10.1016/j.vaccine.2008.04.040. Epub 2008 May 5.

PMID:
18513840
20.

Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age.

Lucero MG, Dulalia VE, Parreno RN, Lim-Quianzon DM, Nohynek H, Makela H, Williams G.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004977. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD004977.

PMID:
15495133
Items per page

Supplemental Content

Write to the Help Desk